Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fitzmaurice

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Health Technology Assessment (Winchester, England)|February 17, 2016
Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluationJoie Ensor, Richard D Riley, Sue Jowett, et al.
Lancet (London, England)|August 19, 2007
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialJonathan Mant, F D Richard Hobbs, Kate Fletcher, et al.
Stroke|April 3, 2014
Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)Nahal Mavaddat, Andrea Roalfe, Kate Fletcher, et al.
International Journal of Cardiology|December 3, 2014
Screening for atrial fibrillation in general practice: a national, cross-sectional study of an innovative technologyGerard Bury, Davina Swan, Walter Cullen, et al.
The Cochrane Database of Systematic Reviews|April 16, 2010
Self-monitoring and self-management of oral anticoagulationJosep M Garcia-Alamino, Alison M Ward, Pablo Alonso-Coello, et al.
BMJ Open|May 6, 2014
Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitorsKaren Kearley, Mary Selwood, Ann Van den Bruel, et al.
Stroke|April 23, 2011
Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillationSue Jowett, Stirling Bryan, Jonathan Mant, et al.
BMC Cancer|August 29, 2006
Prevalence of the use of cancer related self-tests by members of the public: a community surveySue Wilson, Sheila Greenfield, Helen M Pattison, et al.
BMC Cardiovascular Disorders|July 31, 2004
A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]Dawn Swancutt, Richard Hobbs, David Fitzmaurice, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 16, 2022
Two-year outcomes of UK patients newly diagnosed with atrial fibrillation: findings from the prospective observational cohort study GARFIELD-AFPatricia N Apenteng, Saverio Virdone, Fd Richard Hobbs, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Health Technology Assessment (Winchester, England)|February 17, 2016
Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluationJoie Ensor, Richard D Riley, Sue Jowett, et al.
Lancet (London, England)|August 19, 2007
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialJonathan Mant, F D Richard Hobbs, Kate Fletcher, et al.
Stroke|April 3, 2014
Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)Nahal Mavaddat, Andrea Roalfe, Kate Fletcher, et al.
International Journal of Cardiology|December 3, 2014
Screening for atrial fibrillation in general practice: a national, cross-sectional study of an innovative technologyGerard Bury, Davina Swan, Walter Cullen, et al.
The Cochrane Database of Systematic Reviews|April 16, 2010
Self-monitoring and self-management of oral anticoagulationJosep M Garcia-Alamino, Alison M Ward, Pablo Alonso-Coello, et al.
BMJ Open|May 6, 2014
Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitorsKaren Kearley, Mary Selwood, Ann Van den Bruel, et al.
Stroke|April 23, 2011
Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillationSue Jowett, Stirling Bryan, Jonathan Mant, et al.
BMC Cancer|August 29, 2006
Prevalence of the use of cancer related self-tests by members of the public: a community surveySue Wilson, Sheila Greenfield, Helen M Pattison, et al.
BMC Cardiovascular Disorders|July 31, 2004
A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]Dawn Swancutt, Richard Hobbs, David Fitzmaurice, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 16, 2022
Two-year outcomes of UK patients newly diagnosed with atrial fibrillation: findings from the prospective observational cohort study GARFIELD-AFPatricia N Apenteng, Saverio Virdone, Fd Richard Hobbs, et al.
Pageof 8